4.4 Article

Development of a sampling-based global sensitivity analysis workflow for multiscale computational cancer models

Journal

IET SYSTEMS BIOLOGY
Volume 8, Issue 5, Pages 191-197

Publisher

INST ENGINEERING TECHNOLOGY-IET
DOI: 10.1049/iet-syb.2013.0026

Keywords

-

Funding

  1. National Science Foundation (NSF) [DMS-1263742]
  2. NSF SBIR [1315372]
  3. National Institutes of Health (NIH) [1U54CA149196, 1U54CA143837, 1U54CA151668, 1U54CA143907]
  4. University of New Mexico Cancer Center Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer
  5. Methodist Hospital Research Institute
  6. Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging
  7. Department of Radiology at Massachusetts General Hospital
  8. NATIONAL CANCER INSTITUTE [U54CA143837, U54CA149196, U54CA151668, U54CA143907] Funding Source: NIH RePORTER

Ask authors/readers for more resources

There are two challenges that researchers face when performing global sensitivity analysis (GSA) on multiscale 'in silico' cancer models. The first is increased computational intensity, since a multiscale cancer model generally takes longer to run than does a scale-specific model. The second problem is the lack of a best GSA method that fits all types of models, which implies that multiple methods and their sequence need to be taken into account. In this study, the authors therefore propose a sampling-based GSA workflow consisting of three phases - pre-analysis, analysis and post-analysis - by integrating Monte Carlo and resampling methods with the repeated use of analysis of variance; they then exemplify this workflow using a two-dimensional multiscale lung cancer model. By accounting for all parameter rankings produced by multiple GSA methods, a summarised ranking is created at the end of the workflow based on the weighted mean of the rankings for each input parameter. For the cancer model investigated here, this analysis reveals that extracellular signal-regulated kinase, a downstream molecule of the epidermal growth factor receptor signalling pathway, has the most important impact on regulating both the tumour volume and expansion rate in the algorithm used.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available